| RESEARCH HIGHLIGHTS |
“The Wiedemann–Franz law is one of the
major factors that limits the thermoelectric efficiency of conductors,” says Zhou. “The violation of the law may provide an alter- native route to achieving high-efficiency thermoelectric materials.”
The calculations suggest that stanene’s
thermal transport properties could be tuned by altering its chemical potential, he adds, for example by adding traces of other atoms. The team now hopes to calculate how efficiently stanene can generate thermo-
electric power, and the size of the voltage generated by a temperature difference in the material.
1. Zhou, H., Cai, Y., Zhang, G. & Zhang, Y-W. Quantum thermal transport in stanene. Physical Review B 94, 045423 (2016).
Chikungunya
CHILDREN SHRUG OFF DISEASE SYMPTOMS WHILE STILL INFECTIOUS
Children recover from chikungunya viral infection more quickly than adults, which could make them hidden carriers of the disease, finds a team of immunologists and pediatricians in Singapore and Malaysia1. Unlike adults, who typically stay indoors
while the virus is active, children feel less wretched and continue to play outdoors, exposing themselves to mosquitoes. “Some kids
still carry the virus in their blood even when they don’t feel sick anymore, which is scary,” says Lisa F. P. Ng, who led the study at the A*STAR Singapore Immunology Network (SIgN). “It is important to clinically manage children from serving as reservoirs of infection.” Chikungunya is a painful viral disease trans-
mitted via mosquitoes that also carry dengue and the Zika virus. Identified in Tanzania in 1953,
Children infected with the chikungunya virus could infect mosquitoes that spread the disease.
18 A*STAR RESEARCH
MILD SYMPTOMS COULD MEAN THAT
CHILDREN ARE BRINGING THE MOSQUITO- BORNE DISEASE TO THE PLAYGROUND
the virus has since spread worldwide. There are no specific antiviral treatments for chikungunya and vaccines are stalled in preclinical trials. Infected adults typically suffer from fever,
rashes and debilitating joint pain that can persist for months to years. But clinicians at Sarawak General Hospital in Malaysia, led by Ooi Mong How, noticed that children did not suffer as much. They approached Ng and her team to explore the immunological basis for the chills and aches. The team studied blood samples from 86
chikungunya-infected children aged 1 week to 11 years, who visited the hospital between 2009 and 2010. They compared these samples with those of 64 infected adults in Singapore. The children expressed higher levels of small proteins known as cytokines, which communicate information between immune cells. “They have a very active immune response at an early stage, and then it clears off fairly quickly,” explains Ng. The spiked cytokine activity could explain the children’s improved clinical outcomes. The children’s results revealed a more com- plex picture. More than half still had the virus
ISSUE 6 | JANUARY – MARCH 2017
© TacioPhilip/iStock/Getty Images Plus
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56